Maternal Risk Factors for Retinopathy of Prematurity in Korea: A Nationwide Population-Based Study

韩国早产儿视网膜病变母体危险因素:一项全国性人群研究

阅读:3

Abstract

PURPOSE: To investigate the association between maternal health conditions and the risk of retinopathy of prematurity (ROP) in preterm infants using nationwide population-based data. DESIGN: A retrospective cohort study. PARTICIPANTS: A total of 88 111 live preterm births in Korea between January 1, 2014, and December 31, 2017, identified from linked National Health Insurance Service and National Health Screening Program for Infants and Children databases. METHODS: Multivariable logistic regression models were used to estimate adjusted odds ratios (aORs) for maternal risk factors associated with ROP and treatment-requiring ROP. MAIN OUTCOME MEASURES: Incidence of any ROP and treatment-requiring ROP. RESULTS: Of 88 111 preterm infants, 17 181 (19.5%) developed ROP, and 340 (2.0% of ROP cases) required treatment. Maternal diabetes mellitus (aOR, 1.142; P < 0.001), dyslipidemia (aOR, 1.123; P < 0.001), hypertension (aOR, 1.092; P = 0.023), pelvic and genitourinary diseases (aOR, 1.172; P < 0.001), and delivery or placental disorders (aOR, 1.463; P < 0.001) were associated with higher odds of ROP. Among infants with ROP, ovarian dysfunction was associated with increased odds of treatment-requiring disease (aOR, 1.732; P < 0.001), whereas preeclampsia and gestational hypertension were associated with reduced odds (aOR, 0.465; P < 0.001). CONCLUSIONS: Multiple maternal conditions were associated with increased risk of any ROP in preterm infants. Among infants with ROP, ovarian dysfunction independently predicted progression to treatment-requiring disease, whereas preeclampsia and gestational hypertension were associated with reduced risk of severe ROP. Recognition of these maternal risk factors may support prenatal counseling, neonatal risk stratification, and targeted ROP screening. FINANCIAL DISCLOSURES: The authors have no proprietary or commercial interest in any materials discussed in this article.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。